Aims & Scope
CNS & Neurological Disorders – Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.
CNS & Neurological Disorders – Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.
As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Ranking and Category
136th of 253 in Pharmacology & Pharmacy
165th of 256 in Neuroscience
Bentham Press Release — NEWS
- New Issue Published Mini Review in Medicinal Chemistry Vol. 17 Issue 10
- Open Access Article:”The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders”
- Call For Paper
- Free Trial Request
- Most Accessed Article Current and Future Perspectives on the Major Depressive Disorder: Focus on the New Multimodal Antidepressant Vortioxetine
- Open Access Article: Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate
- Call For Paper
- New Issue Published CNS & Neurological Disorders – Drug Targets Vol. 16 Issue 3
- Free Trial Request
- Open Access Article: The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men.
- Most Accessed Article: Novel Therapeutic Strategies for Dementia
- Call For Paper
- Free Trial Request
- Open Access Article: The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders
- Most Accessed Article: In Vitro and In Vivo Models of Multiple Sclerosis
- Free Online Issue CNS & Neurological Disorders Drug Targets Vol. 16 Issue 1
- Call For Paper
- Issue Published CNS & Neurological Disorders Drug Targets Vol. 16 Issue 1
- Most Accessed Article: Translational Challenge Models in Support of Efficacy Studies: Effect of Cerebral Hypoxia on Cognitive Performances in Rodents
- Highlighted Article: Nanomaterials for Neurology: State-of-the-Art
- Open Access Article: The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders
- Most Accessed Article: Brain: The Potential Diagnostic and Therapeutic Target for Glaucoma
- Call For Paper
- Free Trial Request
- Podcast for (Mechlorethamine-based Drug Structures for Intervention of Central Nervous System Tumors)
- Free Online Issue of CNS & Neurological Disorders Drug Targets
- Highlighted Article: Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Disease More Effectively
- Free Trial Request
- Call For Paper
- Highlighted Article: Nanomaterials for Neurology: State-of-the-Art
- Most Cited Article: Citrus Peel Extract Attenuates Acute Cyanide Poisoning-Induced Seizures and Oxidative Stress in Rats
- Podcast on Fish Oil has Beneficial Effects on Behavior Impairment and Oxidative Stress in Rats Subjected to a Hepatic Encephalopathy Model
- Podcast (TRP Channels New Potential Therapeutic Approaches in CNS Neuropathies)
- Podcast Ischemic Pos-Conditioning Partially Reverses Cell Cycle Reactivity Following Ischemia
- Elsevier and Bentham Science agree to a co-distribution alliance
- In cancer and aging, interconnected roles for apoptosis and cellular senescence
- Comments of Editorial Board Member CNS & Neurological Disorders – Drug Targets
- Highlighted Article of the Journal CNS & Neurological Disorders – Drug Targets
- CNS & Neurological Disorders – Drug Targets, 15 Issue 6
- Scholarly Publications by Japanese Authors in BSP Journal: CNS & Neurological Disorders – Drug Targets
- Highlighted Article Flyer for the journal “CNS & Neurological Disorders – Drug Targets”
